Getein Makes Waves at ADLM 2026 – A Strong Showing for IVD Innovation in Anaheim

Booth 1303 Draws Crowds, Multi‑scenario Diagnostic Solutions Spark Enthusiastic Discussions

〈Anaheim, July 28, 2026〉— The 78th ADLM Annual Meeting & Clinical Lab Expo (ADLM 2026) is underway at the Anaheim Convention Center in California. Since the opening, Getein Biotech's booth (No. 1303) has maintained strong momentum, drawing a steady stream of visitors and establishing itself as one of the most notable booths in the diagnostics hall.

Booth Highlights

The Getein team is warmly welcoming partners and professional visitors from North America, Latin America, and Europe. From discussions on precision diagnostic needs to comprehensive solution planning, every in‑depth conversation is paving the way for future collaboration.

As one of the largest and most influential academic events in global laboratory medicine, this year's ADLM (July 26–30) brings together experts, scholars, and industry leaders from around the world. Getein's booth, with its innovative diagnostic concepts and diversified technology displays, has attracted considerable attention and fostered a vibrant atmosphere of professional exchange.

Spotlight on Products

At the exhibition, Getein's multiple innovative products have drawn keen interest from numerous partners and industry professionals.

The comprehensive diagnostic solutions cover key areas including clinical laboratory automation, point‑of‑care testing, molecular diagnostics, and veterinary diagnostics — from high‑throughput automated laboratory lines to flexibly deployable portable POCT devices, building a multi‑scenario diagnostic ecosystem that serves central labs as well as primary care facilities.

The flagship product on display — the Metis 600 Flexible Modular System, combining the MAGICL 6100 chemiluminescence module and the CM‑480 clinical chemistry module — stands out for its compactness and high efficiency, addressing the automation upgrade needs of laboratories of various sizes, and has drawn many visitors for in‑depth discussions.

In the POCT product line, the Getein 1160 and Getein 1150 are showcased side by side. The Getein 1160 is designed for emergency departments and clinical wards, while the Getein 1150 features lightweight deployment and easy operation, ideal for mobile healthcare and community screening. Many partners have shown strong interest in these systems.

In the fields of molecular diagnostics, dry chemistry, and veterinary diagnostics, Getein also presents the GN 7000 PCR Analyzer, the DC 3100 Automated Dry Chemistry Analyzer, and the CM‑50 Vet Automated Biochemical Analyzer, further demonstrating the company's broad portfolio across multiple diagnostic scenarios.

The Show Continues

The ADLM 2026 exhibition is still in full swing (July 28–30). Getein Biotech invites more industry colleagues and partners to visit Booth 1303 and experience the innovative strength of our multi‑scenario diagnostic solutions.

We look forward to connecting with even more partners and exploring new opportunities for collaboration during the remaining days of the show.